Free 15% Customization On All Syndicated Reports.

Global Diabetes Management Market – by Device Type (Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices), by Therapeutics (Injectables, Oral Drugs), and Geography Forecast to 2026

Market Scenario

Diabetes management market size was valued at USD 12.7 billion in 2016 and is projected to reach to USD 61.59 billion at a CAGR of 17.2%. Diabetes Management Market This is a comprehensive global report focused on the current and future prospects of the diabetes management market. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors. An in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements for the diabetes management market has been done in order to calculate the growth rates for each segments and sub-segments. Rising prevalence of diabetes is anticipated to fuel the demand for diabetes management devices and antidiabetic drugs Growing geriatric population, worldwide rising prevalence of diabetes, increasing uptake of novel drugs such as incretin & dipeptidyl inhibitors, technological advancements in diabetes devices, and the presence of government initiatives are factors attributed to the market growth over the forecast period.In addition, increasing prevalence of obesity and growing preference for combination therapy across the world is expected to assist in the market growth. Geriatric population is prone to develop diabetes. According to data provided by the World Health Organization (WHO), the global population aged 60 years and above is anticipated to rise from 841.0 million in 2013 to over 2.0 billion by 2050.WHO further reported that the number of diabetic patients has increased from 108.0 million in 1980 to 422.0 million in 2014. This disease is anticipated be the seventh leading cause of death by 2030. On the contrary, high cost of devices and therapeutics is expected to hinder the market growth over the forecast period. The blood glucose meters, a leading device segment in the diabetes management market On the basis of monitoring device type, the blood glucose meters segment is expected to dominate the market during the forecast period due to increasing need of blood glucose level monitoring in order to manage diabetes effectively. The injectables segment is expected to spearhead the market in next ten years On the basis of therapeutics, the injectables segment is anticipated to hold major chunk of the diabetes management market in near future owing to rising preference for insulin from patients. The dipeptidyl inhibitors segment is expected to register comparatively higher market growth owing to its safe nature and once daily dose regimen. diabetes management market A surge in the number of obese and diabetics in BRICS countries is anticipated to support the market growth over the forecast period Geographically, BRICS countries are expected to hold major share of the market owing to growing geriatric population and increasing incidences of diabetes in Brazil, Russia, India, China, and South Africa. America is also expected to grab substantial market share in next ten years attributed to changing lifestyle of individuals and rising prevalence of diabetes & obesity in the U.S., Canada, and Mexico. Collaboration of pharmaceutical and medical device manufacturers to put diabetes management market on high growth trajectory Major players in this vertical have implemented growth strategies such as new product launch, partnership, collaboration, operational expansion, and merger & acquisition. For instance, in July 2017, ZydusCadila launched Sitagliptin (50 mg/500mg) and Metformin Hydrochloride (50 mg/1000mg) tablets in the U.S. Key Highlights: • Global diabetes management market size analysis and forecast • Comprehensive study and analysis of market drivers, restraints, and opportunities influencing growth of the global diabetes management market • Diabetes management market segmentation on the basis of device type, therapeutics, and geography (regional) • Diabetes management market strategic analysis with respect to individual growth trends, future prospects along with contribution of various sub-market stakeholders have been considered under the scope of study • Diabetes management market analysis and forecast for five major regions such as Americas, Europe except BRICS, Asia Pacific except BRICS, MEA except BRICS, and BRICS countries • Profiling of key industry players, their strategic perspective, market positioning and analysis of core competencies • Competitive landscape of the key players operating in the diabetes management market including competitive developments, investments, and strategic expansion Years that have been considered for the study are as follows: • Base Year – 2016 • Estimated Year – 2017 • Forecast Period – 2017 to 2026 For company profiles, 2016 has been considered as the base year. In cases, wherein information was unavailable for the base year, the years prior to it have been considered. Research Methodology: The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get unbiased idea of the market. This exercise was done at country level to get fair idea of the market in countries considered for this study. Later this country specific data was accumulated to come up with regional numbers and then arrive at global market value for diabetes management market. Some of the key players of the diabetes management market include: • Bayer Healthcare AG • ZydusCadila • BD • Bristol-Myers Squibb Company • Sanofi • Merck & Co. Inc. • F. Hoffmann-La Roche Ltd • Eli Lilly And Company • Novo Nordisk A/S • Medtronic • Insulet Corporation • LifeScan, Inc. Key Target Audience: • Manufacturers in end-use industries • Diabetes management device & drug manufacturers • Investors and financial community professionals • Manufacturing technology providers • Diabetes management device & drug providers • Industry associations • Raw material suppliers • Government agencies • Market research and consulting firms

Scope of the Diabetes Management Market, Report:

The research report segments the diabetes management market based on device type, therapeutics, and geography.

Diabetes Management Market, By Device Type:

• Monitoring Devices • Blood Glucose Meters • Blood Sampling Devices • Lancets • Diagnostic Devices • Hemoglobin A1c Kits • Hemoglobin A1c Meters • Insulin Delivery Devices • Insulin Pens • Insulin Pumps • Insulin Syringes • Others • Diabetes Monitoring Software • Artificial Pancreas Systems

Diabetes Management Market, By Therapeutics:

• Injectables • Insulin • Exenatide • Oral Drugs • Metformin • Sulfonylureas • Alpha-glucosidase Inhibitors • Dipeptidyl Inhibitors •  Thaizolidinediones • Meglitinides • Combination Medications

Diabetes Management Market, By Geography:

• Americas • North America • U.S. • Canada o Latin America Except BRICS • Mexico • Argentina • Chile • Rest of Latin America Except BRICS • Europe Except BRICS • UK • Germany •  France • Italy • Spain •  Sweden • Norway • Netherlands • Rest of Europe Except BRICS • Asia Pacific Except BRICS • Japan • Australia • Singapore • Malaysia • Vietnam • New Zealand • Rest of Asia Pacific Except BRICS • MEA Except BRICS • GCC • Turkey • Israel • Rest of MEA Except BRICS • BRICS • Brazil • Russia • India • China •  South Africa Geographic Analysis: • Breakdown of Americas diabetes management market • Breakdown of Europe except BRICS diabetes management market • Breakdown of Asia Pacific except BRICS diabetes management market • Breakdown of MEA except BRICS diabetes management market • Breakdown of BRICS diabetes management market Available Customizations: Maximize Market Research offers customizations of reports according to the specific requirement of our clients Stem Cell Therapy Market Report 

Table of Contents

Global Diabetes management market

1. INTRODUCTION 1.1 Report Description 1.1.1 Objectives of the Study 1.1.2 Market Scope 1.1.3 Years considered in the study 1.1.4 Currency 1.1.5 Stakeholders 1.2 Target Audience 1.3 Key Takeaways 2. RESEARCH METHODOLOGY 2.1 Research Methodology 2.2 Market Definition 2.3 Assumptions and Acronyms Used 2.4 Data Sources 2.4.1 Secondary 2.4.1.1 Paid 2.4.1.2 Unpaid 2.4.2 Primary 2.5 Analyst tools and models 3. EXECUTIVE SUMMARY 3.1 Global Diabetes Management Market Overview 3.1.1 Global Diabetes Management Market : By Device Type 3.1.2 Global Diabetes Management Market : By Therapeutics 3.1.3 Global Diabetes Management Market : By Region 4. GLOBAL DIABETES MANAGEMENT MARKET OUTLOOK 4.1 Global Diabetes Management Market : Market Definition, Segmentation and Scope of Study 4.2 Global Diabetes Management Market : Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Global Diabetes Management Market : Competitive Analysis 4.3.1 Key Strategic Initiatives 4.3.2 Regional Presence 4.3.3 Product Overview 4.4 Global Diabetes Management Market : Porter’s Analysis 4.5 Global Diabetes Management Market : PESTEL Analysis 4.6 Global Diabetes Management Market : Product Benchmark Analysis 4.7 Global Diabetes Management Market : Company Market Share Analysis 4.8 Global Diabetes Management Market : Key Findings 4.8.1 Global Diabetes Management Market : Top Wining Strategies 4.8.2 Global Diabetes Management Market : Top Investment Pockets 4.8.3 Global Diabetes Management Market : Top Impacting Factors 5. GLOBAL DIABETES MANAGEMENT MARKET, BY DEVICE TYPE 5.1 Global Diabetes Management Market : Device Type segment Market Share analysis 5.2 Global Diabetes Management Market : Device Type segment Market Size and Forecast 2017-2026 5.3 Global Diabetes Management Market by Monitoring Devices 5.4 Global Diabetes Management Market by Blood Glucose Meters 5.5 Global Diabetes Management Market by Blood Sampling Devices 5.6 Global Diabetes Management Market by Lancets 5.7 Global Diabetes Management Market by Diagnostic Devices 5.8 Global Diabetes Management Market by Hemoglobin A1c Kits 5.9 Global Diabetes Management Market by Hemoglobin A1c Meters 5.10 Global Diabetes Management Market by Insulin Delivery Devices 5.11 Global Diabetes Management Market by Insulin Pens 5.12 Global Diabetes Management Market by Insulin Pumps 5.13 Global Diabetes Management Market by Insulin Syringes 5.14 Global Diabetes Management Market by Others 5.15 Global Diabetes Management Market by Diabetes Monitoring Software 5.16 Global Diabetes Management Market by Artificial Pancreas Systems 5.17 Global Diabetes Management Market Benchmarking By Device Type 5.18 Global Diabetes Management Market by Device Type : Key Trends 5.19 Global Diabetes Management Market by Device Type : Key Developments 6. GLOBAL DIABETES MANAGEMENT MARKET , BY THERAPEUTICS 6.1 Global Diabetes Management Market : Therapeutics segment Market Share Analysis 6.2 Global Diabetes Management Market : Therapeutics segment Market Size and Forecast 2017-2026 6.3 Global Diabetes Management Market by Injectables 6.4 Global Diabetes Management Market by Insulin 6.5 Global Diabetes Management Market by Exenatide 6.6 Global Diabetes Management Market by Oral Drugs 6.7 Global Diabetes Management Market by Metformin 6.8 Global Diabetes Management Market by Sulfonylureas 6.9 Global Diabetes Management Market by Alpha-glucosidase Inhibitors 6.10 Global Diabetes Management Market by Dipeptidyl Inhibitors 6.11 Global Diabetes Management Market by Thaizolidinediones 6.12 Global Diabetes Management Market by Meglitinides 6.13 Global Diabetes Management Market by Combination Medications 6.14 Global Diabetes Management Market Benchmarking By Therapeutics 6.15 Global Diabetes Management Market by Therapeutics: Key Trends 6.16 Global Diabetes Management Market by Therapeutics: Key Developments 7. GLOBAL DIABETES MANAGEMENT MARKET , BY GEOGRAPHY 7.1 Global Diabetes Management Market : Market Share Analysis 7.2 Global Diabetes Management Market : Market Size and Forecast 2017-2026 7.3 North America 7.3.1 Overview 7.3.2 Global Diabetes Management Market Size and Forecast, by Device Type 2017-2026 7.3.3 Global Diabetes Management Market Share Analysis , by Device Type 2017-2026 7.3.4 Global Diabetes Management Market Size and Forecast, by Therapeutics 2017-2026 7.3.5 Global Diabetes Management Market Share Analysis , by Therapeutics 2017-2026 7.3.6 Global Diabetes Management Market Size and Forecast, by Organization Size 2017-2026 7.3.7 Global Diabetes Management Market Share Analysis , by Organization Size 2017-2026 7.3.8 Global Diabetes Management Market Size and Forecast, by Industry Vertical 2017-2026 7.3.9 Global Diabetes Management Market Share Analysis , by Industry Vertical 2017-2026 7.4 Europe 7.4.1 Overview 7.4.2 Global Diabetes Management Market Size and Forecast, by Device Type 2017-2026 7.4.3 Global Diabetes Management Market Share Analysis , by Device Type 2017-2026 7.4.4 Global Diabetes Management Market Size and Forecast, by Therapeutics 2017-2026 7.4.5 Global Diabetes Management Market Share Analysis , by Therapeutics 2017-2026 7.4.6 Global Diabetes Management Market Size and Forecast, by Organization Size 2017-2026 7.4.7 Global Diabetes Management Market Share Analysis , by Organization Size 2017-2026 7.4.8 Global Diabetes Management Market Size and Forecast, by Industry Vertical 2017-2026 7.4.9 Global Diabetes Management Market Share Analysis , by Industry Vertical 2017-2026 7.5 Asia Pacific 7.5.1 Overview 7.5.2 Global Diabetes Management Market Size and Forecast, by Device Type 2017-2026 7.5.3 Global Diabetes Management Market Share Analysis , by Device Type 2017-2026 7.5.4 Global Diabetes Management Market Size and Forecast, by Therapeutics 2017-2026 7.5.5 Global Diabetes Management Market Share Analysis , by Therapeutics 2017-2026 7.5.6 Global Diabetes Management Market Size and Forecast, by Organization Size 2017-2026 7.5.7 Global Diabetes Management Market Share Analysis , by Organization Size 2017-2026 7.5.8 Global Diabetes Management Market Size and Forecast, by Industry Vertical 2017-2026 7.5.9 Global Diabetes Management Market Share Analysis , by Industry Vertical 2017-2026 7.6 Latin America, Middle East and Africa 7.6.1 Overview 7.6.2 Global Diabetes Management Market Size and Forecast, by Device Type 2017-2026 7.6.3 Global Diabetes Management Market Share Analysis , by Device Type 2017-2026 7.6.4 Global Diabetes Management Market Size and Forecast, by Therapeutics 2017-2026 7.6.5 Global Diabetes Management Market Share Analysis , by Therapeutics 2017-2026 7.6.6 Global Diabetes Management Market Size and Forecast, by Organization Size 2017-2026 7.6.7 Global Diabetes Management Market Share Analysis , by Organization Size 2017-2026 7.6.8 Global Diabetes Management Market Size and Forecast, by Industry Vertical 2017-2026 7.6.9 Global Diabetes Management Market Share Analysis , by Industry Vertical 2017-2026 7.7 Global Diabetes Management Market Benchmarking By Geography 7.8 Global Diabetes Management Market by Geography : Key Trends 7.9 Global Diabetes Management Market by Geography : Key Developments 8. COMPITITIVE LANDSCAPE 8.1 Global Diabetes Management Market Share/ Positioning Analysis 8.2 Global Diabetes Management Market: Key Innovators 8.3 Global Diabetes Management Market : Company Profiles 8.3.1 Bayer Healthcare AG 8.3.1.1 Overview 8.3.1.2 Product/Service Portfolio 8.3.1.3 Key Financials 8.3.1.4 Strategic Initiatives 8.3.1.5 SWOT Analysis 8.3.1.6 Competitive Assessment 8.3.2 ZydusCadila 8.3.2.1 Overview 8.3.2.2 Product/Service Portfolio 8.3.2.3 Key Financials 8.3.2.4 Strategic Initiatives 8.3.2.5 SWOT Analysis 8.3.2.6 Competitive Assessment 8.3.3 BD 8.3.3.1 Overview 8.3.3.2 Product/Service Portfolio 8.3.3.3 Key Financials 8.3.3.4 Strategic Initiatives 8.3.3.5 SWOT Analysis 8.3.3.6 Competitive Assessment 8.3.4 Bristol-Myers Squibb Company 8.3.4.1 Overview 8.3.4.2 Product/Service Portfolio 8.3.4.3 Key Financials 8.3.4.4 Strategic Initiatives 8.3.4.5 SWOT Analysis 8.3.4.6 Competitive Assessment 8.3.5 Sanofi 8.3.5.1 Overview 8.3.5.2 Product/Service Portfolio 8.3.5.3 Key Financials 8.3.5.4 Strategic Initiatives 8.3.5.5 SWOT Analysis 8.3.5.6 Competitive Assessment 8.3.6 Merck & Co. Inc. 8.3.6.1 Overview 8.3.6.2 Product/Service Portfolio 8.3.6.3 Key Financials 8.3.6.4 Strategic Initiatives 8.3.6.5 SWOT Analysis 8.3.6.6 Competitive Assessment 8.3.7 F. Hoffmann-La Roche Ltd 8.3.7.1 Overview 8.3.7.2 Product/Service Portfolio 8.3.7.3 Key Financials 8.3.7.4 Strategic Initiatives 8.3.7.5 SWOT Analysis 8.3.7.6 Competitive Assessment 8.3.8 Eli Lilly And Company 8.3.8.1 Overview 8.3.8.2 Product/Service Portfolio 8.3.8.3 Key Financials 8.3.8.4 Strategic Initiatives 8.3.8.5 SWOT Analysis 8.3.8.6 Competitive Assessment 8.3.9 Novo Nordisk A/S 8.3.9.1 Overview 8.3.9.2 Product/Service Portfolio 8.3.9.3 Key Financials 8.3.9.4 Strategic Initiatives 8.3.9.5 SWOT Analysis 8.3.9.6 Competitive Assessment 8.3.10 Medtronic 8.3.10.1 Overview 8.3.10.2 Product/Service Portfolio 8.3.10.3 Key Financials 8.3.10.4 Strategic Initiatives 8.3.10.5 SWOT Analysis 8.3.10.6 Competitive Assessment 8.3.11 Insulet Corporation 8.3.11.1 Overview 8.3.11.2 Product/Service Portfolio 8.3.11.3 Key Financials 8.3.11.4 Strategic Initiatives 8.3.11.5 SWOT Analysis 8.3.11.6 Competitive Assessment 8.3.12 LifeScan, Inc. 8.3.12.1 Overview 8.3.12.2 Product/Service Portfolio 8.3.12.3 Key Financials 8.3.12.4 Strategic Initiatives 8.3.12.5 SWOT Analysis 8.3.12.6 Competitive Assessment 9. CONSOLIDATION 9.1 Global Diabetes Management Market: Mergers and Acquisitions 9.1.1 Overview 9.1.2 Global Diabetes Management Market : Key Drivers – By Region 9.1.3 Global Diabetes Management Market : M&A Breakdown 9.1.3.1 Device Type Based 9.1.3.2 Therapeutics Based 9.1.3.3 Niche Based 9.1.3.4 Region Based 9.1.3.5 Asset & Non-Asset Based 9.1.3.6 Venture Capitalist Based 9.2 Fragmentation of Global Diabetes Management Market 9.3 Global Diabetes Management Market : Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 9.4 Global Diabetes Management Market - New/Emerging Models of Partnerships : Key Examples 9.5 Global Diabetes Management Market : New/Emerging Business Models : Key Examples 9.6 Global Diabetes Management Market - Changing Investment Paradigm : Focused areas by Key Players 9.7 Global Diabetes Management Market - Patent Analysis 10. Global Diabetes Management Market : LIST OF TABLES 11. Global Diabetes Management Market: LIST OF FIGURES

Inquiry Before Buying

Request Sample

About This Report

Report ID1114
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us